DVT | Jotup

Sky Harbour Announces Campus Development at Dulles International Airport

Retrieved on:

Mercoledì, Maggio 29, 2024

The Sky Harbour Group Corporation (NYSE American: SKYH, SKYH WS) announced the execution of a lease agreement with the Metropolitan Washington Airports Authority (“MWAA”) for the development of a Sky Harbour Home Base campus at Dulles International Airport (IAD), Greater Washington DC’s international gateway airport.

Key Points:

The Sky Harbour Group Corporation (NYSE American: SKYH, SKYH WS) announced the execution of a lease agreement with the Metropolitan Washington Airports Authority (“MWAA”) for the development of a Sky Harbour Home Base campus at Dulles International Airport (IAD), Greater Washington DC’s international gateway airport.
The Sky Harbour campus, to be developed on approximately 18 acres, is expected to create or sustain hundreds of local jobs and generate significant economic benefits to Northern Virginia.
The campus will offer “the best home base in business aviation” to house Washington, DC area’s top corporate and privately-owned business jets in state-of-the art hangars, with line-services dedicated exclusively to based tenants, offering “the shortest time to wheels-up in business aviation.”
Dulles International Airport joins Sky Harbour campus locations now operating at Houston’s Sugar Land Regional Airport (SGR), Nashville International Airport (BNA), Miami Opa-Locka Executive Airport (OPF), and San Jose Mineta Airport (SJC); and campuses in development at Denver Centennial Airport (APA), Phoenix Deer Valley Airport (DVT), Dallas Addison Airport (ADS), Chicago Executive Airport (PWK), Bradley International Airport (BDL), Hudson Valley Regional Airport (POU), Orlando Executive Airport (ORL), and Stewart International Airport (SWF); with additional campuses soon to be announced.
Our partnership with Sky Harbour symbolizes the Airports Authority's commitment to ensuring IAD remains at the forefront of meeting current and future demand for aeronautical services in the Washington area.”
Tal Keinan, Sky Harbour’s Chairman and Chief Executive Officer, commented, “Dulles International Airport is business aviation’s gateway to our nation’s capital and a Sky Harbour National Tier-1 airport.

Sky Harbour Group Announces Campus Development at Stewart International Airport

Retrieved on:

Martedì, Maggio 28, 2024

The Sky Harbour Group Corporation (NYSE American: SKYH, SKYH WS) today announced that the Port Authority of New York and New Jersey (PANYNJ) voted to authorize the execution of a lease agreement for the development of a Sky Harbour campus at Stewart International Airport (SWF), serving the New York Metropolitan Area.

Key Points:

The Sky Harbour Group Corporation (NYSE American: SKYH, SKYH WS) today announced that the Port Authority of New York and New Jersey (PANYNJ) voted to authorize the execution of a lease agreement for the development of a Sky Harbour campus at Stewart International Airport (SWF), serving the New York Metropolitan Area.
The Stewart International Airport campus joins Sky Harbour campuses now operating at Houston’s Sugar Land Regional Airport (SGR), Nashville International Airport (BNA), Miami Opa-Locka Executive Airport (OPF), and San Jose Mineta Airport (SJC); campuses in development at Denver Centennial Airport (APA), Phoenix Deer Valley Airport (DVT), Dallas’s Addison Airport (ADS), Chicago Executive Airport (PWK), Bradley International Airport (BDL), Hudson Valley Regional Airport (POU), and Orlando Executive Airport (ORL); and additional campuses soon to be announced.
Tal Keinan, Sky Harbour’s Chairman and Chief Executive Officer, commented, “Sky Harbour’s Stewart International Airport campus will be the third Sky Harbour facility to serve the New York metropolitan area, the nation’s top market for business aviation.
Sky Harbour is honored to be joining the PANYNJ community and committed to delivering the long-term benefits of a Sky Harbour campus to the Cities of Newburgh and New Windsor, to Orange County, and to New York State.

One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)

Retrieved on:

Lunedì, Maggio 13, 2024

Health, Medical Devices, Surgery, General Health, Clinical Trials, Research, Science, Thrombosis, Patient, Embolism, DVT, PTAB, MD, Incidence, Journal, Freedom, Vascular disease, Multimedia, SFA

Endologix LLC , a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, has announced the online publication of the one-year results of the DETOUR2 Trial in the Journal of Vascular Surgery ( JVS1 ).

Key Points:

Endologix LLC , a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, has announced the online publication of the one-year results of the DETOUR2 Trial in the Journal of Vascular Surgery ( JVS1 ).
Percutaneous Transmural Arterial Bypass (PTAB) with the DETOUR System offers a novel approach to bypass the SFA using the vein as a conduit.
The study highlighted low rates of complications, deep venous thrombosis (DVT), and clinically-driven target lesion revascularization (CD-TLR), and excellent one-year primary patency.
DETOUR2 trial outcomes demonstrate clinical utility of percutaneous transmural bypass for the treatment of long segment, complex femoropopliteal disease.

SonoVascular Enters into Strategic Collaboration with Lantheus Holdings, Inc. for Use of Microbubbles in Combination with SonoThrombectomy™ System for Treatment of Venous Thromboembolism

Retrieved on:

Giovedì, Maggio 2, 2024

Safety, VTE, FIH, Partnership, Pulmonary embolism, Patient, DVT, Catheter, Microbubble, Vein, Coronary thrombosis, Deep vein thrombosis

VTE is a condition that occurs when a blood clot forms in a deep vein, resulting in DVT.

Key Points:

VTE is a condition that occurs when a blood clot forms in a deep vein, resulting in DVT.
The microbubbles are activated by intravascular ultrasound and will be investigated in ongoing pre-clinical and upcoming clinical studies.
The SonoThrombectomy System has been engineered to address and overcome the deficiencies and limitations of current interventional devices.
Additionally, upon completion of a FIH study, SonoVascular has an option to enter into a long-term exclusive commercial supply agreement with Lantheus.

Coinstore New Public Chain Forum “Finding the Future Alpha” Has Completed Successfully

Retrieved on:

Lunedì, Aprile 22, 2024

XRP, Cardano, VCS, MSB, CMO, DFG, Nifedipine, ETF, Ecosystem, Capital, Telco, Conflux, AI, BTC, CEX, RWA, Wi-Fi, Research, SOL, Gold, Roam, BSC, IVC, Optimism, DVT, Logic, ICO, Meme, ATH, AVAX, Partner, SSV, Cryptocurrency

Singapore, April 22, 2024 (GLOBE NEWSWIRE) -- Global top crypto asset platform, Coinstore, held a new public chain forum called “Finding the Future Alpha - Will Solana lead the next boom? ''

Key Points:

Singapore, April 22, 2024 (GLOBE NEWSWIRE) -- Global top crypto asset platform, Coinstore, held a new public chain forum called “Finding the Future Alpha - Will Solana lead the next boom? ''
Before the forum, Coinstore has rich experience in holding events,and has actively published Cryptalk and CS Connect events.To date, Coinstore held more than 30 Cryptalk, nearly 40 CS Connect and 22 Expo conferences.
This public chain forum will become a benchmark forum.
Coinstore will hold more forums and events in the future to promote the collision of technology, capital, and new ideas, and bring innovation to the crypto industry.

Keysight Secures New Test Case Validations for Narrowband Non-Terrestrial Networks Standard

Retrieved on:

Lunedì, Aprile 29, 2024

The new NB-IoT NTN conformance test case validations cover transmitter and receiver, demodulation, and radio resource management (RRM).

Key Points:

The new NB-IoT NTN conformance test case validations cover transmitter and receiver, demodulation, and radio resource management (RRM).
These test case validations also enable Keysight to support certification testing at GCF Recognized Test Organizations (RTO).
The test cases are managed through the Keysight ATLAS Test Management Center , the company’s new framework for automated acceptance testing.
Notable test case validations included RRM RedCap for single receiver and inter-radio access technology with EUTRA.

Avalanche Technology Achieves ISO 9001:2015 Certification, Demonstrating Commitment to Quality Assurance and Technological Excellence

Retrieved on:

Lunedì, Aprile 15, 2024

Petro, Internet, Orbital, Certification, Engagement, Communication, ISO, ISO 9001, DVT, QMS, Customer, MRAM, International Organization (journal), Audit

FREMONT, Calif., April 15, 2024 /PRNewswire-PRWeb/ -- Avalanche Technology, the leader in next generation MRAM technology, has earned its ISO 9001:2015/Full Design certification, effective immediately. The certification reflects Avalanche's exceptional quality assurance processes. Perry Johnson Registrars, a leading expert in the testing, inspection, and certification sector, conducted the rigorous assessment. Registrar founder Perry L. Johnson is one of the world's foremost authorities in quality, having written more than 15 manuals covering topics from Total Quality Management to Statistical Process Control and ISO/QS-9000.

Key Points:

The ISO 9001 designation is the world's most widely recognized quality management standard (QMS), set by the International Organization of Standardization in Geneva, Switzerland.
Avalanche's approach to achieving high quality includes many disciplines and processes:
Reliability certification of technology development at Avalanche foundries.
The technical complexity in addressing these challenges shows the value of ISO 9001 certification, where quality underscores all development processes.
For more information on how Avalanche is meeting its commitment to this standard, read about Avalanche's approach to quality .

National Blood Clot Alliance Names Corewell Health a Center of Excellence

Retrieved on:

Mercoledì, Aprile 10, 2024

Education, Patient, Hospital, VTE, Certification, NBCA, COE, Butterworth Hospital, Pulmonary embolism, Survivor, DVT, National Blood Clot Alliance, Health, Deep vein thrombosis, Coronary thrombosis, Nursing

PHILADELPHIA, April 10, 2024 /PRNewswire/ -- National Blood Clot Alliance ® (NBCA) today announced that Corewell Health™ Grand Rapids Hospitals – Butterworth Hospital has been named the inaugural NBCA Center of Excellence in the United States.

Key Points:

PHILADELPHIA, April 10, 2024 /PRNewswire/ -- National Blood Clot Alliance ® (NBCA) today announced that Corewell Health™ Grand Rapids Hospitals – Butterworth Hospital has been named the inaugural NBCA Center of Excellence in the United States.
By designating Corewell Health a Center of Excellence, we are acknowledging its commitment to both clinical excellence and patient education," said Board Member and NBCA Committee Chair Justin Crockett.
In designating Corewell Health as an NBCA Center of Excellence, the committee highlighted both the qualitative and quantitative multidisciplinary, systematic approach to DVT and PE treatment.
"This formal recognition speaks highly of the demonstrated excellence of Corewell Health's program treating patients with acute and chronic VTE," said Alejandro Quiroga, M.D., president, Corewell Health in West Michigan.

Award-winning Director Kurosawa Kiyoshi Pioneers Theater-to-Web3 Movie Distribution Model with Intertrust Supertickets on Nekojarashi’s Roadstead.io

Retrieved on:

Martedì, Aprile 9, 2024

Nekojarashi, Inc. and Intertrust today announced they will debut Chime, a film by celebrated director, Kurosawa Kiyoshi, through a unique Web3 collaboration on Nekojarashi’s Digital Video Trading (DVT) Platform, Roadstead.io .

Key Points:

Nekojarashi, Inc. and Intertrust today announced they will debut Chime, a film by celebrated director, Kurosawa Kiyoshi, through a unique Web3 collaboration on Nekojarashi’s Digital Video Trading (DVT) Platform, Roadstead.io .
Superticket purchasers will have exclusive rights to Chime, which will be available worldwide on April 12, 2024, Japan Standard Time.
In an unprecedented move for a Kurosawa film, Chime introduces a unique viewing experience through limited-edition Supertickets, available only for a month post-opening.
It is a crazy movie, a bizarre movie, and that is what this film is about,” said Kurosawa Kiyoshi.

Clarius and ThinkSono Introduce a New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs

Retrieved on:

Venerdì, Aprile 5, 2024

Cloud, CE marking, Diagnosis, Deep vein thrombosis, Algorithm, Partnership, Research, Class, AI, Patient, Leg, DVT, Temple Health, SDK, Marketing, Nursing, FDA, Clarius, Medical device

VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, and ThinkSono, a pioneering medical technology company specializing in ultrasound artificial intelligence (AI) guidance solutions, are introducing a new AI-guided ultrasound system in Europe, which will improve the efficiency of detecting deep vein thrombosis (DVT). ThinkSono Guidance, an AI App that pairs with Clarius ultrasound scanners, recently attained Class llb CE mark regulatory approval.

Key Points:

ThinkSono Guidance, an AI App that pairs with Clarius ultrasound scanners, recently attained Class llb CE mark regulatory approval.
ThinkSono Guidance enables non-ultrasound trained healthcare professionals to use the Clarius handheld ultrasound scanner to collect DVT exam data for a qualified clinician to review.
ThinkSono now uses Clarius' Solum software development kit (SDK), enabling the company to create a bespoke solution tailored to their DVT application.
The Clarius SDK suite empowers third party developers to seamlessly integrate AI-powered ultrasound software with Clarius handheld ultrasound systems, the Clarius App, and the Clarius Cloud exam management platform.